Toll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-κB in prostate cancer cells

2009 ◽  
Vol 37 (4) ◽  
pp. 1849-1855 ◽  
Author(s):  
Jin Ming Di ◽  
Jun Pang ◽  
Qi Peng Sun ◽  
Yan Zhang ◽  
You Qiang Fang ◽  
...  

2007 ◽  
Vol 177 (4S) ◽  
pp. 93-93
Author(s):  
Makoto Sumitomo ◽  
Kenji Kuroda ◽  
Takako Asano ◽  
Akio Horiguchi ◽  
Keiichi Ito ◽  
...  




2021 ◽  
Author(s):  
Merve Nur İNCE ◽  
Asuman DEVECİ ÖZKAN ◽  
Erhan BEZDEGÜMELİ ◽  
Ahmet Yasir MEN ◽  
Bilge Nur KÜÇÜKAKÇA ◽  
...  


2012 ◽  
Vol 28 (4) ◽  
pp. 269-277 ◽  
Author(s):  
Yuntao Zhang ◽  
Yong Wang ◽  
Jianlin Yuan ◽  
Weijun Qin ◽  
Fei Liu ◽  
...  


2010 ◽  
Vol 1 (3) ◽  
pp. 495-499 ◽  
Author(s):  
QI SU ◽  
RUI-PENG JIA ◽  
JIANZHONG LIN ◽  
LU-WEI XU ◽  
ZI-ZHENG WANG ◽  
...  


2018 ◽  
Vol 399 (4) ◽  
pp. 387-395 ◽  
Author(s):  
Ming Sun ◽  
Donghua Geng ◽  
Shuqiang Li ◽  
Zhaofu Chen ◽  
Wenyan Zhao

AbstractWe investigated thoroughly the effect of lncRNA PART1 on prostate cancer cells proliferation and apoptosis, through regulating toll-like receptor (TLR) pathways. LncRNA PART1 expression was also examined by quantitative real-time polymerase chain reactions (qRT-PCR) in human tissues and the cells lines LNCaP and PC3. After transfection with si-PART1 or control constructs, the cell viability was measured by MTS and colony formation assays. In addition, the apoptosis rate of the prostate cancer cells was validated by TUNEL staining. Relationships between lncRNA PART1 expression and TLR pathway genes were demonstrated by qRT-PCR and Western blotting. High levels of lncRNA PART1 expression were correlated with advanced cancer stage and predication of poor survival. LncRNA PART1 levels was increased in PCa cells treated with 5α-dihydrotestosterone (DHT), confirming PART1 was directly induced by androgen. Moreover, down-regulation of lncRNA PART1 inhibited prostate cancer cell proliferation and accelerated cell apoptosis. In addition, lncRNA PART1 induced downstream genes expression in TLR pathways includingTLR3,TNFSF10andCXCL13to further influence prostate cancer cells, indicating its carcinogenesis on prostate cancer. LncRNA PART1 promoted cell proliferation ability and apoptosis via the inhibition of TLR pathways in prostate cancer. LncRNA PART1 could hence be considered as a new target in the treatment of prostate cancer.



2011 ◽  
Vol 12 (1) ◽  
pp. 29 ◽  
Author(s):  
Xiaodong Wen ◽  
Celia Chao ◽  
Kirk Ives ◽  
Mark R Hellmich


2003 ◽  
Vol 160 (6) ◽  
pp. 617-621 ◽  
Author(s):  
Lingyun Li ◽  
Kirsten K. Steinauer ◽  
Amie J. Dirks ◽  
Bryan Husbeck ◽  
Iris Gibbs ◽  
...  


2000 ◽  
Vol 275 (15) ◽  
pp. 11397-11403 ◽  
Author(s):  
Ao-Lin Hsu ◽  
Tsui-Ting Ching ◽  
Da-Sheng Wang ◽  
Xueqin Song ◽  
Vivek M. Rangnekar ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document